Back
Putnam BDC Income ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
53
PBDC
Putnam BDC Income ETF
Last Price:
$34.87
Seasonality Move:
-0.21%
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
$312.03
Seasonality Move:
15.43%
Buy
53
Putnam BDC Income ETF (PBDC)
is a Buy
Is Putnam BDC Income ETF a Buy, Sell or Hold?
-
The current Putnam BDC Income ETF [PBDC] share price is $34.48. The Score for PBDC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
PBDC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals [MDGL] share price is $310.87. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PBDC Stock Price Chart
What is Putnam BDC Income ETF's stock price today?
-
The Putnam BDC Income ETF share price today is $34.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBDC is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $310.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
PBDC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 54.98 | Buy |
| Chaikin Money Flow: | 7906 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34 - 34.72) | Buy |
| Bollinger Bands (100): | (32.87 - 34.19) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 52.32 | Buy |
| Chaikin Money Flow: | 181247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (302.79 - 330.27) | Sell |
| Bollinger Bands (100): | (218.22 - 310.12) | Buy |
PBDC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.41 | Buy |
| 20-day SMA: | 34.5 | Sell |
| 50-day SMA: | 33.9 | Buy |
| 200-day SMA: | 33.75 | Buy |
| 8-day EMA: | 34.37 | Buy |
| 20-day EMA: | 34.33 | Buy |
| 50-day EMA: | 34.04 | Buy |
| 200-day EMA: | 33.4 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 303.77 | Buy |
| 20-day SMA: | 315.09 | Sell |
| 50-day SMA: | 290.91 | Buy |
| 200-day SMA: | 257.5 | Buy |
| 8-day EMA: | 306 | Buy |
| 20-day EMA: | 308.74 | Buy |
| 50-day EMA: | 295 | Buy |
| 200-day EMA: | 259.53 | Buy |
Putnam BDC Income ETF Earnings Growth & PBDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.
Putnam BDC Income ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||